Drägerwerk AG & Co. KGaA (pref)
Research Drägerwerk AG & Co. KGaA (pref) (DRW3) on Bullrun: valuation model: 15.7% undervalued, market cap EUR 1.79B, P/E 12.1, dividend yield 2.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDRW3
- ExchangeXETRA
- CountryGermany
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Valuation signal15.7% undervalued
- Market capEUR 1.79B
- P/E12.1
- Dividend yield2.1%
- Financial periodQ2 2026
- RevenueEUR 847.31M
- Net incomeEUR 29.52M
- Gross margin46.6%
Valuation Snapshot
Bullrun's latest valuation model marks Drägerwerk AG & Co. KGaA (pref) as 15.7% undervalued; latest market cap is EUR 1.79B; P/E is 12.1; dividend yield is 2.1%.
Peer valuation comparison
Latest P/E is 12.14x versus a Healthcare sector median of 24.46x (50.4% below).
Latest dividend yield is 2.05% versus a Healthcare sector median of 2.11% (2.8% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 3.48B | EUR 139.50M | n/a | 45.2% | n/a | EUR 266.13M | EUR 405.11M | EUR 1.63B |
| FY2024 | EUR 3.37B | EUR 124.41M | n/a | 44.9% | n/a | EUR 223.47M | EUR 395.58M | EUR 1.54B |
| FY2023 | EUR 3.37B | EUR 110.44M | n/a | 43.3% | n/a | EUR 271.96M | n/a | n/a |
| FY2022 | EUR 3.05B | -EUR 64.56M | n/a | 40.7% | n/a | EUR 311.55M | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 1.79B | 12.1 | 2.1% | 2.27 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.27 EUR, yield 2.1%.
About Drägerwerk AG & Co. KGaA (pref)
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Drägerwerk AG & Co. KGaA (pref) overvalued or undervalued?
Bullrun's valuation model currently marks Drägerwerk AG & Co. KGaA (pref) as 15.7% undervalued.
What is Drägerwerk AG & Co. KGaA (pref)'s market cap?
Drägerwerk AG & Co. KGaA (pref)'s market capitalization is EUR 1.79B.
What is Drägerwerk AG & Co. KGaA (pref)'s P/E ratio?
Drägerwerk AG & Co. KGaA (pref)'s price-to-earnings (P/E) ratio is 12.1.
Does Drägerwerk AG & Co. KGaA (pref) pay a dividend?
Drägerwerk AG & Co. KGaA (pref) has a dividend yield of 2.1%.
What does Drägerwerk AG & Co. KGaA (pref) do?
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection.